Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy
PHASE1CompletedINTERVENTIONAL
Enrollment
35
Participants
Timeline
Start Date
December 31, 1996
Study Completion Date
October 31, 2000
Conditions
Brain NeoplasmsNeuroblastoma
Interventions
DRUG
phenylbutyrate
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001565 - Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy | Biotech Hunter | Biotech Hunter